|Articles|June 9, 2021
Supplements and Featured Publications
- Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities
Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities
Advertisement
Although type 1 diabetes (T1D) includes a reasonably small patient population, it does impose a significant impact on patients, caregivers, payers, and society. This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of T1D to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
5